Talicia® is indicated for the treatment of Helicobacter pylori infection in adults
Patients can now access RedHill’s Talicia® via the PhilRx Platform
Phil Inc., a patient access platform company that revolutionizes life science product commercialization, today announced an agreement with RedHill Biopharma (NASDAQ:RDHL) (‘RedHill’) to make its medication Talicia® (omeprazole magnesium, amoxicillin, and rifabutin) available via the PhilRx Patient Access Platform.
The PhilRx Patient Access Platform provides end-to-end visibility into the entire prescription life cycle, starting the moment the physician writes a prescription. HCPs can send an electronic prescription (eRx) for Talicia® to PhilRx directly from their electronic health record (EHR). The PhilRx Patient Access Platform simplifies the prior authorization process (PA) for physicians by allowing them to submit PAs for the medication with just one-click, streamlining the insurance coverage process for patients and increasing the chances of insurance reimbursement.
The partnership between Phil and RedHill enables patients to receive Talicia® prescriptions quickly, easily, and affordably. Using the PhilRx Patient Access Platform, patients can fill their prescription, review prescription records, and obtain assistance navigating insurance benefits.
“RedHill is focused on advancing gastrointestinal and infectious diseases management through innovation, dedication, and a collective mindset of delivering on our promises. Our partnership with Phil will elevate our ability to eliminate access barriers to Talicia®,” said Ben Sloan, VP of Market Access at RedHill. “We are continually seeking ways to streamline prior authorizations and help patients navigate their insurance coverage, and the PhilRx platform will address and simplify these complex processes.”
Talicia® is approved for the treatment of H. pylori, a common gastrointestinal (GI) bacterial infection that damages tissue in the stomach. While most people have H. pylori bacteria for years, many do not experience symptoms. In some cases, though, the infection can cause redness and swelling of the stomach lining. H. pylori is the main cause of peptic ulcers, and it can also cause gastritis and stomach cancer.
“H. pylori affects approximately 35% of adult Americans, and these conditions often go undiagnosed or untreated,” said Patrick Leary, Chief Commercial Officer, Phil. “Phil’s modern technology platform aims to improve the prescription process for life science companies, physicians, and patients – and working alongside RedHill to improve access to medication has the potential to transform their brand and positively impact patients.”
Learn more about the PhilRx Patient Access Platform.
